BioSpace News Archive

IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced an update on their NSERC-funded partnership with the

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore” or the “Company”) has achieved significant milestones in completing due diligence, technical reviews and initial connectivity between its real-time data reporting platform, HealthTab™ and a leading point-of-care device

BetterLife Pharma Inc. an emerging biotech company, is pleased to announce that it will be teaming up with VirTrial, LLC to conduct patient monitoring for their imminent COVID 19 clinical trials in Australia to test the efficacy of AP-003, a proprietary interferon alpha 2b formulation.

Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, and University of Dundee, a top-ranked university in the UK for biological sciences, announced today a research collaboration agreement with the aim to identify and develop a novel class of medicines that target and degrade disease-causing proteins

Kaiser Permanente announced that a multidisciplinary team of sports medicine physicians, infectious disease, and other specialists has developed and released comprehensive guidance for youth, high school, and collegiate athletes to return to sports safely during the COVID-19 pandemic.

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal’ or the “Company”) and PL Developments (PLD) today announced that they have commenced shipments of store brand equivalent Voltaren® Arthritis Pain Gel (diclofenac sodium topical gel, 1%) in 50, 100 and 150g laminate tubes following FDA clearance.

Crown Bioscience today announces the appointment of Pam Shang as vice president for global quality. Mrs. Shang will be instrumental in further enhancing global quality across the company, leveraging her deep expertise in implementing quality systems for pharma and biotechnology clients including in GLP, GMP and other regulated environments. This press release features multimedia. View the full release here: https://www.busi

The growth of the global d-dimer testing market is ascribed to its high demand across the globe.

The emergence of the life science industry and increasing healthcare facilities have accelerated the adoption of analytical instruments and methods in research activities.

Obesity is a disorder in which excess body fat gets accumulated to such extent that it may have negative effects on health.